Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
NEW YORK (Reuters Health) – Metallic stents used to relieve malignant ureteral obstruction may not perform any better than conventional polyurethane stents, according to a new study. “We…
NEW YORK (Reuters Health) – Adding gemtuzumab ozogamicin (GO) to induction chemotherapy improved survival in older patients with acute myeloid leukemia (AML), with no apparent additional toxicity, in…
How does the body store the toxins and xenoestrogens we ingest with our food? Robert Berger, PhD and Editor-in-Chief of Nutricula Magazine, discusses how these substances get stored in fat…
It’s highly debated whether patients undergoing radiation therapy for prostate cancer should also have their lymph nodes treated. Janna Andrews, MD, discusses the RTOG trials and their results, which…
With the continual advancement of technology in surgery, one would expect that robotic prostatectomy to be the gold standard of treatment for prostate cancer. However, Judd Moul, MD,…
Charles Jungreis, MD, Chairperson, Department of Radiology, Professor, Temple University School of Medicine, discusses stereotactic radiosurgery. References and Resources Cesaretti JA, Pennathur A, Rosenstein BS, Swanson SJ, Fernando…
Judd Moul, MD, explains why he disagrees with the recent move by the US Preventive Services Task Force to give the routine PSA exam a D-rating. He discusses…
Janna Andrews, MD takes us for a tour of the latest technological advancements in the field of radiation therapy delivery for prostate cancer treatment. She explains the benefits…
